Cure8 research brief
VEO-IBD often presents with severe, extensive disease and can include monogenic causes and early hepatobiliary complications; knowing common presentations and early management patterns helps families and clinicians plan evaluation and testing.
Parents and caregivers of children diagnosed with VEO-IBD or IO-IBD, pediatric gastroenterologists, clinicians ordering genetic testing, and researchers studying pediatric IBD genetics and hepatobiliary complications.
This report looked at 52 children diagnosed from 2010–2025 at a tertiary Australian centre. Disease severity at presentation was substantial (median PUCAI 35). Among those genotyped, two monogenic disorders were identified and managed with bone marrow transplant.
PSC was diagnosed within 12 months in about 8% of the cohort, highlighting early hepatobiliary involvement in some young children. Corticosteroids were used commonly (67%) and most responded; a minority required anti-TNF therapy and one child underwent early colectomy.
The study supports using phenotype to guide genetic testing in very young children with IBD and suggests further study of early PSC in this population. These findings come from a single centre and are descriptive rather than demonstrating treatment effects.
This is a retrospective, single-centre cohort (52 children) with data through 2025 and the content depth is abstract-based. Results are descriptive; genetic findings were limited to the subset who underwent testing. Incidence and outcomes may differ in other centres or populations.
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
This study provides region-specific pediatric IBD data from the Philippines, highlighting prevalence of very-early-onset disease, perianal involvement in Crohn's, and factors (diagnostic delay, wasting, pancolitis)...
This study describes how IBD presents and early outcomes in children at a tertiary center, noting high rates of inflammation, nutritional problems, and early flares. Findings may help families and clinicians understand...
Fatigue affects a large majority of pediatric IBD patients and is linked to worse quality of life even when disease is in remission, so it’s a common problem families and clinicians will likely encounter. Understanding...
